NIGHT FEVER
LIVE

Serial Number

79329519

Owner

BIOFAR

Attorney

Mary Margaret L. O'Donnell

Filing Date

Nov 30, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NIGHT FEVER Trademark

Serial Number: 79329519 • Registration: 7574572

NIGHT FEVER is a trademark filed by BIOFAR on November 30, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

BIOFAR (7 trademarks)

6, rue des Marguerites
F-92000 NANTERRE , FR

Entity Type: 99

Trademark Details

Filing Date

November 30, 2021

Registration Date

November 26, 2024

Published for Opposition

September 24, 2024

Goods & Services

Pharmaceutical preparations, dietetic foods adapted for medical use, dietetic substances adapted for paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations, parapharmaceutical products and food supplements for medical and paramedical use, namely, pharmaceutical preparations, parapharmaceutical products and food supplements for medical and paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products made from plants, extracts of plants and vegetable extracts in effervescent and other forms for enhancing energy production in the body; pharmaceutical preparations and parapharmaceutical products containing minerals and vitamins in effervescent and other forms; vitamins and minerals in effervescent and other forms, namely, granules; pharmaceutical preparations and parapharmaceutical products for phytotherapy; food supplements for medical use as additions to the nutrient intake in a normal diet; nutritional supplements for paramedical use for enhancing energy production in the body as additions to the nutrient intake in a normal diet, which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; all dietetic substances adapted for medical and paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; food supplements for medical use prepared for human consumption from food ingredients of vegetable and mineral origin; nutritional supplements for paramedical use prepared for human consumption from food ingredients of vegetable and mineral origin, which may contain proteins, carbohydrates, lipids, and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body; fortifying foodstuffs for medical use; fortifying foodstuffs for paramedical use which may contain proteins, carbohydrates, lipids and fibres, and micronutrients such as vitamins and minerals, amino acids and fatty acids, in individual doses such as capsules, effervescent tablets, non-effervescent tablets, pills, gelatin capsules, sachets, chewing gums, dry extracts and powders for pharmaceutical and parapharmaceutical use, granular powders, cellulose microspheres impregnated with active depurative ingredients for enhancing energy production in the body

Filing History

CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 2, 2026 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 9, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 18, 2025 FICS
FINAL DISPOSITION PROCESSED
Apr 18, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 26, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 26, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 26, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 4, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 21, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 8, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 8, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 8, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 10, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 10, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 10, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 10, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 10, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 10, 2023 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 11, 2023 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 24, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 24, 2023 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 9, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 9, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 9, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 9, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 9, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 9, 2023 COAR
REFUSAL PROCESSED BY IB
Dec 11, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 21, 2022 RFCS
REFUSAL PROCESSED BY MPU
Nov 21, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2022 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 9, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 7, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 3, 2022 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Dec 27, 2021 SDRC